Instrument Inactif

Autres langues LA JOLLA PHARM Other OTC

Actions

Recherche biotechnologique et médicale

Cours en clôture Other OTC
- ^USD	-

22/08/22	La Jolla Pharmaceutical annonce des changements de direction	CI
22/08/22	Innoviva, Inc. (NasdaqGS:INVA) a finalisé l'acquisition de La Jolla Pharmaceutical Company (NasdaqCM:LJPC).	CI

Autres langues

22/08/22	La Jolla Pharmaceutical : Termination of a Material Definitive Agreement - Form 8-K
22/08/22	LA JOLLA PHARMACEUTICAL CO : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
22/08/22	La Jolla Pharmaceutical Announces Management Changes
22/08/22	La Jolla Pharmaceutical Company(NasdaqCM:LJPC) dropped from NASDAQ Composite Index
22/08/22	La Jolla Pharmaceutical Company(NasdaqCM:LJPC) dropped from S&P TMI Index
22/08/22	Innoviva, Inc. completed the acquisition of La Jolla Pharmaceutical Company for approximately $210 million.
15/08/22	LA JOLLA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
15/08/22	Tranche Update on La Jolla Pharmaceutical Company's Equity Buyback Plan announced on November 17, 2021.
15/08/22	La Jolla Pharmaceutical Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
12/07/22	LA JOLLA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of La Jolla Pharmaceutical Company - LJPC
11/07/22	Twitter, Las Vegas Sands fall; Mullen, La Jolla rise
11/07/22	Sector Update: Health Care Stocks Edging Lower at Close
11/07/22	Top Midday Gainers
11/07/22	Innoviva Agrees to Take La Jolla Pharmaceutical Private in $149 Million Acquisition Deal; Shares Rise
11/07/22	La Jolla Pharmaceutical : Innoviva to Acquire La Jolla Pharmaceutical Company - Form 8-K
11/07/22	LA JOLLA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
11/07/22	Innoviva to Acquire La Jolla Pharmaceutical Company
11/07/22	La Jolla Pharmaceutical Company Equity Buyback announced on November 17, 2021, has expired, in connection with the announced merger, the stock repurchase plan was cancelled effective July 11, 2022.
11/07/22	Innoviva, Inc. entered into a definitive merger agreement to acquire La Jolla Pharmaceutical Company for approximately $160 million.
16/05/22	La Jolla Pharmaceutical: Q1 Earnings Snapshot
16/05/22	La Jolla Pharmaceutical's Earnings Decline in March Quarter, Sales Increase
16/05/22	Earnings Flash (LJPC) LA JOLLA PHARMACEUTICAL COMPANY Reports Q1 Revenue $10.4M
16/05/22	LA JOLLA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
16/05/22	La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Corporate Progress
16/05/22	Tranche Update on La Jolla Pharmaceutical Company's Equity Buyback Plan announced on November 17, 2021.